Skip to main content
. 2017 Oct 20;7:13658. doi: 10.1038/s41598-017-13287-2

Figure 1.

Figure 1

Concordance between Roche TaqMan and GeneXpert assays. Percentages of samples reported ‘detected’ or ‘not detected’ using the qualitative Xpert HIV-1 Qual (a,b) and quantitative HIV-1 Viral Load cartridges (c,d), with and without incorporating a 3 minute centrifugation step from a 100 µl whole blood finger-prick sample. Panels a. and c. show participants with undetectable plasma viraemia using the Roche TaqMan assay tested using whole blood finger-prick samples using the GeneXpert Qual and Viral Load cartridges, respectively. Panels b and d show participants with detectable viraemia using the Roche TaqMan assay tested using the Qual and Viral Load cartridges, respectively. Arrows indicate the impact of introducing a 3 minute centrifugation ‘spin’ step to the protocol.